1. Home
  2. DNN vs VKTX Comparison

DNN vs VKTX Comparison

Compare DNN & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Denison Mines Corp (Canada)

DNN

Denison Mines Corp (Canada)

HOLD

Current Price

$3.31

Market Cap

3.3B

ML Signal

HOLD

Logo Viking Therapeutics Inc.

VKTX

Viking Therapeutics Inc.

HOLD

Current Price

$29.94

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DNN
VKTX
Founded
1954
2012
Country
Canada
United States
Employees
N/A
N/A
Industry
Other Metals and Minerals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.7B
IPO Year
1998
2014

Fundamental Metrics

Financial Performance
Metric
DNN
VKTX
Price
$3.31
$29.94
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
10
Target Price
$6.50
$88.00
AVG Volume (30 Days)
42.3M
2.2M
Earning Date
03-10-2026
04-22-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$237.62
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.08
$18.92
52 Week High
$4.43
$43.15

Technical Indicators

Market Signals
Indicator
DNN
VKTX
Relative Strength Index (RSI) 38.24 39.28
Support Level $2.56 $25.67
Resistance Level $3.36 $30.15
Average True Range (ATR) 0.22 1.91
MACD -0.05 -0.43
Stochastic Oscillator 4.07 1.05

Price Performance

Historical Comparison
DNN
VKTX

About DNN Denison Mines Corp (Canada)

Denison Mines Corp is a uranium exploration and development company focused on the Athabasca Basin region of northern Saskatchewan, Canada. The company holds a noteworthy 95% interest in its flagship Wheeler River Uranium Project, the undeveloped uranium project located in the infrastructure-rich eastern part of the Athabasca Basin. Additionally, it is involved in mine decommissioning and environmental services through its Closed Mines group, which manages the Elliot Lake reclamation projects and offers third-party post-closure mine care and maintenance services. The Company operates in two main segments: the Mining segment and the Corporate and Other segment. The majority of revenue is generated from the mining segment.

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Share on Social Networks: